Wide spectrum of disease ranging from subclinical to end-stage liver disease
∼ 20-40% of chronic alcoholics who undergo biopsy have histologic evidence of alcoholic liver disease (ALD)
Clinical Issues
•
Very variable presentation
•
Moderately elevated transaminases (AST/ALT ratio typically >2)
Microscopic
•
Combination of hepatocyte injury, inflammation, steatosis, and fibrosis
Hepatocytic ballooning
Lobular inflammation with predominance of neutrophils
Mallory-Denk bodies (Mallory hyaline)
Megamitochondria
Steatosis
Fibrosis
–
Most often pericellular and perivenular, especially initially
•
Cholestatic features may be seen
•
Iron deposition in hepatocytes and Kupffer cells is common
Top Differential Diagnoses
•
Nonalcoholic steatohepatitis (NASH)
Histology of ALD and NASH virtually identical; favor ALD when Mallory bodies, neutrophil aggregates, or sclerosing hyaline necrosis is present
•
Chronic hepatitis C
Many patients have both ALD and hepatitis C infection
TERMINOLOGY
Abbreviations
•
Alcoholic liver disease (ALD)
Definitions
•
Hepatocyte injury and inflammation resulting from chronic alcohol consumption
Wide spectrum of clinical and pathologic disease ranging from mild/subclinical to end-stage cirrhosis and death
ETIOLOGY/PATHOGENESIS
Alcohol Consumption
•
Alcohol is direct hepatotoxin
•
Both genetic and environmental factors determine susceptibility to liver injury
CLINICAL ISSUES
Epidemiology
•
Incidence
∼ 20-40% of chronic alcoholics who undergo biopsy have histologic evidence of ALD